VEGFA and neoplasm: In addition, LMWH reverses the immunosuppressive microenvironment by reducing hypoxia and inhibiting VEGF, promoting effector T-cell activity, reducing fibroblast activation and fibrosis, and enhancing drug delivery within the tumor microenvironment.